Prognosis in antiphospholipid syndrome

Authors
Citation
Mc. Amigo, Prognosis in antiphospholipid syndrome, RHEUM DIS C, 27(3), 2001, pp. 661
Citations number
51
Categorie Soggetti
Rheumatology
Journal title
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
ISSN journal
0889857X → ACNP
Volume
27
Issue
3
Year of publication
2001
Database
ISI
SICI code
0889-857X(200108)27:3<661:PIAS>2.0.ZU;2-D
Abstract
Antiphospholipid syndrome (APS) has a broad clinical spectrum. As a result, the prognosis may differ depending on the specific subset of APS being con sidered. There are patients with mild APS and patients with a more severe d isease. Pulmonary hypertension, neurologic involvement, myocardial ischemia , nephropathy, gangrene of the extremities and especially, the catastrophic antiphospholipid syndrome are associated with a worse prognosis. In additi on, apart from fetal loss and pregnancy complications, APS patients have a substantial risk of thrombosis during pregnancy and the postpartum period. Follow-up studies have shown that having APS, whether primary or secondary, confers a poor prognosis.